We have s t u d i e d a 6 month o l d female who had two episodes o f lethargy, hepatomegaly, metabolic acidosis, and hypoglycemia w i t h o u t k e t o s i s . She had p e r s i s t a n t hypocarni tinemia (avg f r e e 3 . 6 1~ M, ester. 4 . 7~ M; n l f r e e 48+8, e s t e r . 6+3). Dicarboxylic a c i d u r i a (C6-10) was present during b u t n o t retween episodes. Extracts o f h e r c u l t u r e d s k i n f i b r o b l a s t s had d e f i c i e n t MCD a c t i v i t y : p a t i e n t < 0.09 mU/mg; c o n t r o l s (n=9) 1.85-3.66. A c t i v it i e s o f palmi t y l -, b u t y r y l -and isovaleryl-CoA dehydrogenases
were normal. We compared her response t o a 12 hour f a s t before and a f t e r 1 month o f therapy w i t h 100mg/kg/d L -c a r n i t i n e (C) Fast hours sympt g l u c HCO, f r e e C ester. C 6-OHB AcAc pre-C 0 n l 966 100 Also, pre-C f a s t i n g induced marked C6-10 d i c a r b o x y l i c a c i d u r i a accompanied by accumulation o f C10-14 f a t t y acids i n plasma. On C, u r i n a r y d i c a r b o x y l i c acids peaked a t <20% o f pre-C l e v e l s w i t h l i t t l e o r no accumulation o f C10-14 f a t t y acids i n plasma.
We conclude 1) MCD d e f i c i e n c y i s associated w i t h episodic acidosis, d i c a r b o x y l i c a c i d u r i a and C deficiency; 2) administrat i o n o f C improved tolerance t o f a s t i n g ; 3) care should be taken t o d i s t i n g u i s h MCD d e f i c i e n c y from o t h e r causes o f C deficiency. The i n v i v o e f f e c t s o f glycerol-%phosphate ( G~P ) on lucone g e n e 7 f r o n t a l a n i n e (!l a, h e r e inve:tigated i n w e l l Yc) and ra?nour?sted (M) r a t s . S~x t y t o 80 g W~s t a r r a t s were made M by feeding a 4% p r o t e i n ( P r t ) , 54% carbohydrate (Cho) d i e t f o r 4 weeks. C were f e d a d i e t w i t h 279 P r t and 63% Cho. Both aroups received eaual amounts o f f a t , vitamins and minerals. zfte; an o v e r n i g h t f a s t t h e r a t s r e c i f v e d a s i n g l e 1.p. dose of A! a ( 1 g/kg), w i t h o r w i t h o u t p r i o r priming w i t h 2 g l k g G3P. 30 min before Ala. Blood glucose (Glc) l e v e l s were monitored f o r 2 h r and noted as changes over baseline. The r e s u l t s i n d i c a t e :
ALTERATIONS OF GLUCONEOGENESIS IN VIVO BY GLYCEROL-
(1) Both groups o f r a t s produced 61c from Ala a t the same r a t e (F=2.89; df=1,60; NS). (2) When G3P was i n j e c t e d before Ala, blood Glc declined i n M r a t s t o l e v e l s below baseline beginn i n g 60 min a f t e r Ala a d m i n i s t r a t i o n fF=EP.8; df=1,60; PtO.OO1, compared t o !.la alone). C r a t s had no i n h i b i t i o n o f Glc f o rmaticn by G3P. Conclusions: i n M r a t s , G3P a d m i n i s t r a t i o n i nh i b i t s normal gluconeogenesis from Ala, i n c o n t r a s t t o C r a t s . i n which both substrates show no i n t e r a c t i o n . Therefore, these data support t h e view t h a t n u t r i t i o n a l s t a t u s may p l a y a r o l e i n tolerance t o g l y c e r o l , t h e metabolic precursor o f 6?P, esp e c i a l l y e a r l y i n l i f e .
GLYCOGEN IN FETAL LAMB LIVER I S INCREASED DURING
CHRONIC HYPERGLYCEMIA AND HYPERINSULINEMIA.
David Warburton. (Spon. by T.G. Keens).
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I studied the developmental p r o f i l e o f glycogen, glycogen synthase and phosphorylase i n l i v e r s o f c o n t r o l f e t a l lambs a t 123, 131, and 142d g e s t a t i o n (term 150d) and i n t h e l i v e r s o f t h e i r twins given intravenous glucose (16+2 mglkglmin, MiSE) from 112d onwards.
Serum glucose (34t2 mgldl) and i n s u l i n (47511 pU/ml) i n the glucose t r e a t e d fetuses were higher than serum glucose (19i3 mgldl, P < 0.01) and i n s u l i n (14i2 uU/ml, P < 0.01) i n the c o n t r o l s . To investigate the acute effects of CHL on energy metabolism we have studied its effects on oxidative activity in isolated mitochondria from adult rat and newborn pig hearts. We have previously shown acutely reduced myocardial function in newborn pig hearts in the presence of CHL. Respiratory substrates provided were pyruvate(PYR)/malate(MA~) 7.114.7mM. glutamate(GLU) 18mM. durohydroquinone(DHQ) 1.62mM, a-ketoglutarate(AKG) 5mM, and succinate(SUC) 1 M . State 3(ADP-stimulated) oxidation of PYR, MAL, GLU, and DHQ was unaffected or only mildly affected in the presence of CHL concentrations as high as 500 pg/ml. Oxidation of AKG and SUC was inhibited 39 and 55% respectively in rat and to a similar degree in pig heart by 50 pglrnl CHL. State 4 oxidation was relatively unaffected. SUC oxidation was also observed in sonicated mitochondria and was unaffected by CHL, suggestingthat transport was the limiting factor in SUC oxidation. Measurement of SUC accumulation in mitochondria showed transport to be reduced 75-84% in the presence of CHL (500 uglml). Studies in the presence of phthalonate indicated that succinate is primarily transported by the AKG carrier in the heart. CHL also inhibited mitochondria1 AKG release in the presence of MAL and GLU indicating impairment of the malatelaspartate shuttle by CHL. Impairment of the malatelaspartate shuttle resulting from inhibition of the AKG carrier may contribute to the acute clinical toxicity of CHL. Children's Hospital, Univ. of Cincinnati Pulmonary glycogen serves as substrate for surfactant lipid synthesis by Type I1 cells during the perinatal period. Glycogen is depleted from these cells in association with activation of phosphorylase (phos b). Phos b is phosphorylated to phos a by phosphorylase kinase (PK). The present study tests the hypothesis that known depletion of pulmonary glycogen is associated with ontogenic changes in PK. Lung PK wa& quantitated by phosphorylation of endogenous and exogeneous phos b assessed by SDS-PAGE and autoradiography. 3 2~-~h o s a was the major ca2+-dep phospho-protein in fetal lung cytosol by 2-D, IEF-PAGE, co-migrating with purified muscle enzyme. PK increased from day 17 to 20-21 gestation declining to undetectable levels wtthin a week of age. PK was caZ+-dependent, EC50 ca2+ 10-'~. Exogenous phos b w s readily phosphorylated by fetal but not adult cytosol. Added purified exogenous PK did not enhance 32~-phos a in postnatal lung. PK was also demonstrated in purified Type I1 cells from rat. Activity was highest 16 hrs after isolation, decreasing during culture 3-4d. Conclusion: phosphorylase kinase activity was identified in cytosol from both Type I1 cells and fetal lung. PK increases prtor to birth and decreases dramatically postnatally. Decreases in both phos b (substrate) and phosphorylase kinase may account for known postnatal decreases in phos a activity. High PK activity is associated wlth glycogen depletion and surfactant synthesis in the Type I1 cells at 20-21d gestation in the rat.
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